 | • レポートコード：MRC2-11QY09629 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は天然痘ワクチンのグローバル市場について調査・分析したレポートです。種類別（一代、二代、三代）市場規模、用途別（公立病院・プログラム、私立病院・クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別天然痘ワクチンの競争状況、市場シェア ・世界の天然痘ワクチン市場：種類別市場規模 2015年-2020年（一代、二代、三代） ・世界の天然痘ワクチン市場：種類別市場規模予測 2021年-2026年（一代、二代、三代） ・世界の天然痘ワクチン市場：用途別市場規模 2015年-2020年（公立病院・プログラム、私立病院・クリニック） ・世界の天然痘ワクチン市場：用途別市場規模予測 2021年-2026年（公立病院・プログラム、私立病院・クリニック） ・北米の天然痘ワクチン市場分析：米国、カナダ ・ヨーロッパの天然痘ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの天然痘ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の天然痘ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの天然痘ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bavarian Nordic、CEL-SCI、Chimerix、EpiVax、Nanotherapeutics、Oncovir、SIGA Technologies、Symphogen、TapImmune、Tonix Pharmaceuticals Holding ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Smallpox vaccine develops immunity and protect people from smallpox. This smallpox vaccine is made from the virus called Vaccinia.
Rising demand from Asia-Pacific region a major driver for the growth of the Smallpox Vaccine market.
Market Analysis and Insights: Global Smallpox Vaccine Market
The global Smallpox Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Smallpox Vaccine Scope and Market Size
Smallpox Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Smallpox Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Smallpox Vaccine market is segmented into
First Generation
Second Generation
Third Generation
Segment by Application, the Smallpox Vaccine market is segmented into
Government Hospital And Program
Private Hospitals / Clinicss
Regional and Country-level Analysis
The Smallpox Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Smallpox Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Smallpox Vaccine Market Share Analysis
Smallpox Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Smallpox Vaccine business, the date to enter into the Smallpox Vaccine market, Smallpox Vaccine product introduction, recent developments, etc.
The major vendors covered:
Bavarian Nordic
CEL-SCI
Chimerix
EpiVax
Nanotherapeutics
Oncovir
SIGA Technologies
Symphogen
TapImmune
Tonix Pharmaceuticals Holding
1 Study Coverage
1.1 Smallpox Vaccine Product Introduction
1.2 Market Segments
1.3 Key Smallpox Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Smallpox Vaccine Market Size Growth Rate by Type
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.5 Market by Application
1.5.1 Global Smallpox Vaccine Market Size Growth Rate by Application
1.5.2 Government Hospital And Program
1.5.3 Private Hospitals / Clinicss
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Smallpox Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Smallpox Vaccine Revenue 2015-2026
2.1.2 Global Smallpox Vaccine Sales 2015-2026
2.2 Global Smallpox Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Smallpox Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Smallpox Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Smallpox Vaccine Competitor Landscape by Players
3.1 Smallpox Vaccine Sales by Manufacturers
3.1.1 Smallpox Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Smallpox Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Smallpox Vaccine Revenue by Manufacturers
3.2.1 Smallpox Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Smallpox Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Smallpox Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Smallpox Vaccine Revenue in 2019
3.2.5 Global Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Smallpox Vaccine Price by Manufacturers
3.4 Smallpox Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Smallpox Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Smallpox Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Smallpox Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Smallpox Vaccine Market Size by Type (2015-2020)
4.1.1 Global Smallpox Vaccine Sales by Type (2015-2020)
4.1.2 Global Smallpox Vaccine Revenue by Type (2015-2020)
4.1.3 Smallpox Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Smallpox Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Smallpox Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Smallpox Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Smallpox Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Smallpox Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Smallpox Vaccine Market Size by Application (2015-2020)
5.1.1 Global Smallpox Vaccine Sales by Application (2015-2020)
5.1.2 Global Smallpox Vaccine Revenue by Application (2015-2020)
5.1.3 Smallpox Vaccine Price by Application (2015-2020)
5.2 Smallpox Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Smallpox Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Smallpox Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Smallpox Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Smallpox Vaccine by Country
6.1.1 North America Smallpox Vaccine Sales by Country
6.1.2 North America Smallpox Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Smallpox Vaccine Market Facts & Figures by Type
6.3 North America Smallpox Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Smallpox Vaccine by Country
7.1.1 Europe Smallpox Vaccine Sales by Country
7.1.2 Europe Smallpox Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Smallpox Vaccine Market Facts & Figures by Type
7.3 Europe Smallpox Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Smallpox Vaccine by Region
8.1.1 Asia Pacific Smallpox Vaccine Sales by Region
8.1.2 Asia Pacific Smallpox Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Smallpox Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Smallpox Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Smallpox Vaccine by Country
9.1.1 Latin America Smallpox Vaccine Sales by Country
9.1.2 Latin America Smallpox Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Smallpox Vaccine Market Facts & Figures by Type
9.3 Central & South America Smallpox Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Smallpox Vaccine by Country
10.1.1 Middle East and Africa Smallpox Vaccine Sales by Country
10.1.2 Middle East and Africa Smallpox Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Smallpox Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Smallpox Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Corporation Information
11.1.2 Bavarian Nordic Description and Business Overview
11.1.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bavarian Nordic Smallpox Vaccine Products Offered
11.1.5 Bavarian Nordic Related Developments
11.2 CEL-SCI
11.2.1 CEL-SCI Corporation Information
11.2.2 CEL-SCI Description and Business Overview
11.2.3 CEL-SCI Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CEL-SCI Smallpox Vaccine Products Offered
11.2.5 CEL-SCI Related Developments
11.3 Chimerix
11.3.1 Chimerix Corporation Information
11.3.2 Chimerix Description and Business Overview
11.3.3 Chimerix Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Chimerix Smallpox Vaccine Products Offered
11.3.5 Chimerix Related Developments
11.4 EpiVax
11.4.1 EpiVax Corporation Information
11.4.2 EpiVax Description and Business Overview
11.4.3 EpiVax Sales, Revenue and Gross Margin (2015-2020)
11.4.4 EpiVax Smallpox Vaccine Products Offered
11.4.5 EpiVax Related Developments
11.5 Nanotherapeutics
11.5.1 Nanotherapeutics Corporation Information
11.5.2 Nanotherapeutics Description and Business Overview
11.5.3 Nanotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Nanotherapeutics Smallpox Vaccine Products Offered
11.5.5 Nanotherapeutics Related Developments
11.6 Oncovir
11.6.1 Oncovir Corporation Information
11.6.2 Oncovir Description and Business Overview
11.6.3 Oncovir Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Oncovir Smallpox Vaccine Products Offered
11.6.5 Oncovir Related Developments
11.7 SIGA Technologies
11.7.1 SIGA Technologies Corporation Information
11.7.2 SIGA Technologies Description and Business Overview
11.7.3 SIGA Technologies Sales, Revenue and Gross Margin (2015-2020)
11.7.4 SIGA Technologies Smallpox Vaccine Products Offered
11.7.5 SIGA Technologies Related Developments
11.8 Symphogen
11.8.1 Symphogen Corporation Information
11.8.2 Symphogen Description and Business Overview
11.8.3 Symphogen Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Symphogen Smallpox Vaccine Products Offered
11.8.5 Symphogen Related Developments
11.9 TapImmune
11.9.1 TapImmune Corporation Information
11.9.2 TapImmune Description and Business Overview
11.9.3 TapImmune Sales, Revenue and Gross Margin (2015-2020)
11.9.4 TapImmune Smallpox Vaccine Products Offered
11.9.5 TapImmune Related Developments
11.10 Tonix Pharmaceuticals Holding
11.10.1 Tonix Pharmaceuticals Holding Corporation Information
11.10.2 Tonix Pharmaceuticals Holding Description and Business Overview
11.10.3 Tonix Pharmaceuticals Holding Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tonix Pharmaceuticals Holding Smallpox Vaccine Products Offered
11.10.5 Tonix Pharmaceuticals Holding Related Developments
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Corporation Information
11.1.2 Bavarian Nordic Description and Business Overview
11.1.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bavarian Nordic Smallpox Vaccine Products Offered
11.1.5 Bavarian Nordic Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Smallpox Vaccine Market Estimates and Projections by Region
12.1.1 Global Smallpox Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Smallpox Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Smallpox Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Smallpox Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Smallpox Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Smallpox Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Smallpox Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Smallpox Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Smallpox Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Smallpox Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Smallpox Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Smallpox Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Smallpox Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Smallpox Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Smallpox Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Smallpox Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Smallpox Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Smallpox Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Smallpox Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Smallpox Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Smallpox Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Smallpox Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Smallpox Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Smallpox Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Smallpox Vaccine Market Segments
Table 2. Ranking of Global Top Smallpox Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Smallpox Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of First Generation
Table 5. Major Manufacturers of Second Generation
Table 6. Major Manufacturers of Third Generation
Table 7. Global Smallpox Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Smallpox Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Smallpox Vaccine Sales by Regions 2015-2020 (K Units)
Table 10. Global Smallpox Vaccine Sales Market Share by Regions (2015-2020)
Table 11. Global Smallpox Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Smallpox Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Smallpox Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Smallpox Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Smallpox Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Smallpox Vaccine as of 2019)
Table 16. Smallpox Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Smallpox Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Smallpox Vaccine Price (2015-2020) (USD/Unit)
Table 19. Smallpox Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Smallpox Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Smallpox Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Smallpox Vaccine Sales by Type (2015-2020) (K Units)
Table 24. Global Smallpox Vaccine Sales Share by Type (2015-2020)
Table 25. Global Smallpox Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Smallpox Vaccine Revenue Share by Type (2015-2020)
Table 27. Smallpox Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Smallpox Vaccine Sales by Application (2015-2020) (K Units)
Table 29. Global Smallpox Vaccine Sales Share by Application (2015-2020)
Table 30. North America Smallpox Vaccine Sales by Country (2015-2020) (K Units)
Table 31. North America Smallpox Vaccine Sales Market Share by Country (2015-2020)
Table 32. North America Smallpox Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Smallpox Vaccine Revenue Market Share by Country (2015-2020)
Table 34. North America Smallpox Vaccine Sales by Type (2015-2020) (K Units)
Table 35. North America Smallpox Vaccine Sales Market Share by Type (2015-2020)
Table 36. North America Smallpox Vaccine Sales by Application (2015-2020) (K Units)
Table 37. North America Smallpox Vaccine Sales Market Share by Application (2015-2020)
Table 38. Europe Smallpox Vaccine Sales by Country (2015-2020) (K Units)
Table 39. Europe Smallpox Vaccine Sales Market Share by Country (2015-2020)
Table 40. Europe Smallpox Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Smallpox Vaccine Revenue Market Share by Country (2015-2020)
Table 42. Europe Smallpox Vaccine Sales by Type (2015-2020) (K Units)
Table 43. Europe Smallpox Vaccine Sales Market Share by Type (2015-2020)
Table 44. Europe Smallpox Vaccine Sales by Application (2015-2020) (K Units)
Table 45. Europe Smallpox Vaccine Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Smallpox Vaccine Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Smallpox Vaccine Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Smallpox Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Smallpox Vaccine Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Smallpox Vaccine Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Smallpox Vaccine Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Smallpox Vaccine Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Smallpox Vaccine Sales Market Share by Application (2015-2020)
Table 54. Latin America Smallpox Vaccine Sales by Country (2015-2020) (K Units)
Table 55. Latin America Smallpox Vaccine Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Smallpox Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Smallpox Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Latin America Smallpox Vaccine Sales by Type (2015-2020) (K Units)
Table 59. Latin America Smallpox Vaccine Sales Market Share by Type (2015-2020)
Table 60. Latin America Smallpox Vaccine Sales by Application (2015-2020) (K Units)
Table 61. Latin America Smallpox Vaccine Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Smallpox Vaccine Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Smallpox Vaccine Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Smallpox Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Smallpox Vaccine Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Smallpox Vaccine Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Smallpox Vaccine Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Smallpox Vaccine Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Smallpox Vaccine Sales Market Share by Application (2015-2020)
Table 70. Bavarian Nordic Corporation Information
Table 71. Bavarian Nordic Description and Major Businesses
Table 72. Bavarian Nordic Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Bavarian Nordic Product
Table 74. Bavarian Nordic Recent Development
Table 75. CEL-SCI Corporation Information
Table 76. CEL-SCI Description and Major Businesses
Table 77. CEL-SCI Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. CEL-SCI Product
Table 79. CEL-SCI Recent Development
Table 80. Chimerix Corporation Information
Table 81. Chimerix Description and Major Businesses
Table 82. Chimerix Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Chimerix Product
Table 84. Chimerix Recent Development
Table 85. EpiVax Corporation Information
Table 86. EpiVax Description and Major Businesses
Table 87. EpiVax Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. EpiVax Product
Table 89. EpiVax Recent Development
Table 90. Nanotherapeutics Corporation Information
Table 91. Nanotherapeutics Description and Major Businesses
Table 92. Nanotherapeutics Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Nanotherapeutics Product
Table 94. Nanotherapeutics Recent Development
Table 95. Oncovir Corporation Information
Table 96. Oncovir Description and Major Businesses
Table 97. Oncovir Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Oncovir Product
Table 99. Oncovir Recent Development
Table 100. SIGA Technologies Corporation Information
Table 101. SIGA Technologies Description and Major Businesses
Table 102. SIGA Technologies Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. SIGA Technologies Product
Table 104. SIGA Technologies Recent Development
Table 105. Symphogen Corporation Information
Table 106. Symphogen Description and Major Businesses
Table 107. Symphogen Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Symphogen Product
Table 109. Symphogen Recent Development
Table 110. TapImmune Corporation Information
Table 111. TapImmune Description and Major Businesses
Table 112. TapImmune Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. TapImmune Product
Table 114. TapImmune Recent Development
Table 115. Tonix Pharmaceuticals Holding Corporation Information
Table 116. Tonix Pharmaceuticals Holding Description and Major Businesses
Table 117. Tonix Pharmaceuticals Holding Smallpox Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Tonix Pharmaceuticals Holding Product
Table 119. Tonix Pharmaceuticals Holding Recent Development
Table 120. Global Smallpox Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Smallpox Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Smallpox Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Smallpox Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Smallpox Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Smallpox Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Smallpox Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Smallpox Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Smallpox Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Smallpox Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Smallpox Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Smallpox Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Smallpox Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Smallpox Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Smallpox Vaccine Players
Table 138. Smallpox Vaccine Customers List
Table 139. Smallpox Vaccine Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Smallpox Vaccine Product Picture
Figure 2. Global Smallpox Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. First Generation Product Picture
Figure 4. Second Generation Product Picture
Figure 5. Third Generation Product Picture
Figure 6. Global Smallpox Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Government Hospital And Program
Figure 8. Private Hospitals / Clinicss
Figure 9. Smallpox Vaccine Report Years Considered
Figure 10. Global Smallpox Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Smallpox Vaccine Sales 2015-2026 (K Units)
Figure 12. Global Smallpox Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Smallpox Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Smallpox Vaccine Sales Market Share by Region in 2019
Figure 15. Global Smallpox Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Smallpox Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Smallpox Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Smallpox Vaccine Revenue in 2019
Figure 19. Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Smallpox Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Smallpox Vaccine Sales Market Share by Type in 2019
Figure 22. Global Smallpox Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Smallpox Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Smallpox Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Smallpox Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Smallpox Vaccine Sales Market Share by Application in 2019
Figure 27. Global Smallpox Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Smallpox Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Smallpox Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Smallpox Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Smallpox Vaccine Sales Market Share by Country in 2019
Figure 32. North America Smallpox Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Smallpox Vaccine Market Share by Type in 2019
Figure 38. North America Smallpox Vaccine Market Share by Application in 2019
Figure 39. Europe Smallpox Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Smallpox Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Smallpox Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Smallpox Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Smallpox Vaccine Market Share by Type in 2019
Figure 54. Europe Smallpox Vaccine Market Share by Application in 2019
Figure 55. Asia Pacific Smallpox Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Smallpox Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Smallpox Vaccine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Smallpox Vaccine Revenue Market Share by Region in 2019
Figure 59. China Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Smallpox Vaccine Market Share by Type in 2019
Figure 82. Asia Pacific Smallpox Vaccine Market Share by Application in 2019
Figure 83. Latin America Smallpox Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Smallpox Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Smallpox Vaccine Sales Market Share by Country in 2019
Figure 86. Latin America Smallpox Vaccine Revenue Market Share by Country in 2019
Figure 87. Mexico Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Smallpox Vaccine Market Share by Type in 2019
Figure 94. Latin America Smallpox Vaccine Market Share by Application in 2019
Figure 95. Middle East and Africa Smallpox Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Smallpox Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Smallpox Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Smallpox Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Smallpox Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Smallpox Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Smallpox Vaccine Market Share by Type in 2019
Figure 106. Middle East and Africa Smallpox Vaccine Market Share by Application in 2019
Figure 107. North America Smallpox Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Smallpox Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Smallpox Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Smallpox Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Smallpox Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Smallpox Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Smallpox Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Smallpox Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Smallpox Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Smallpox Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- アデノウイルスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Adenovirus Vaccine Market The global Adenovirus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adenovirus Vaccine Scope and Market Size Adenovirus Vaccine market is segment…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …
- 獣医クロストリジウムワクチンの世界市場（～2026年） Market Analysis and Insights: Global Veterinary Clostridium Vaccine Market The global Veterinary Clostridium Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Clostridium Vaccine Scope and Market Size …